1. Home
  2. RAPP vs CIM Comparison

RAPP vs CIM Comparison

Compare RAPP & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$29.33

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo Chimera Investment Corporation

CIM

Chimera Investment Corporation

HOLD

Current Price

$13.57

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAPP
CIM
Founded
2022
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
RAPP
CIM
Price
$29.33
$13.57
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$47.00
$15.25
AVG Volume (30 Days)
269.3K
1.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
10.89%
EPS Growth
83.64
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$6.20
Revenue Next Year
N/A
$1.32
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.43
$9.85
52 Week High
$42.27
$14.88

Technical Indicators

Market Signals
Indicator
RAPP
CIM
Relative Strength Index (RSI) 55.20 58.72
Support Level $24.45 $12.61
Resistance Level $29.51 $14.23
Average True Range (ATR) 2.11 0.37
MACD 0.18 0.04
Stochastic Oscillator 63.81 74.08

Price Performance

Historical Comparison
RAPP
CIM

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About CIM Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

Share on Social Networks: